(WO/2008/070150) SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS
- Biblio. Data
- Description
- Claims
- National Phase
- Notices
- Documents
| Latest bibliographic data on file with the International Bureau
| ||||||||||||
| ||||||||||||
| IPC: | A01N 43/54 (2006.01), A61K 31/517 (2006.01) | |||||||||||
| Applicants: | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT [DE/DE]; Müllerstrasse 178, 13353 Berlin (DE) (All Except US). HENTEMANN, Martin [US/US]; (US) (US Only). WOOD, Jill [US/US]; (US) (US Only). SCOTT, William [US/US]; (US) (US Only). MICHELS, Martin [DE/DE]; (DE) (US Only). CAMPBELL, Ann-marie [US/US]; (US) (US Only). BULLION, Ann-marie [US/US]; (US) (US Only). ROWLEY, R., Bruce [US/US]; (US) (US Only). REDMAN, Aniko [HU/US]; (US) (US Only). | |||||||||||
| Inventors: | HENTEMANN, Martin; (US). WOOD, Jill; (US). SCOTT, William; (US). MICHELS, Martin; (DE). CAMPBELL, Ann-marie; (US). BULLION, Ann-marie; (US). ROWLEY, R., Bruce; (US). REDMAN, Aniko; (US). | |||||||||||
| Agent: | GRAY, William et al.; Bayer Pharmaceuticals Corporation, 400 Morgan Lane, West Haven, Connecticut 06516 (US). | |||||||||||
| Priority Data: |
| |||||||||||
| Title: | SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS | |||||||||||
| Abstract: | This invention relates to novel 2,3-dihydroimidazo[1,2-c]quinazoline compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for phosphotidylinositol-3-kinase (PI3K) inhibition and treating diseases associated with phosphotidylinositol-3-kinase (PI3K) activity, in particular treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients. | |||||||||||
| Designated States: |
AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. African Regional Intellectual Property Org. (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW) Eurasian Patent Organization (EAPO) (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM) European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR) African Intellectual Property Organization (OAPI) (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG). | |||||||||||
| Publication Language: | English (EN) |
| Filing Language: | English (EN) |
